The in vivo antitumor activity in 22Rν1 tumor-bearing athymic nude mice after oral treatment with EGCG-CS-NPs exhibited significantly higher tumor inhibition and prostate-specific antigen levels compared to free EGCG. This evidence concerns the gene KLK3 and neoplasm.